Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Invest New Drugs. 2018 Apr 3;36(6):1016–1025. doi: 10.1007/s10637-018-0591-z

Figure 1.

Figure 1

Duration of Treatment by Tumor Type in the Dose-Expansion Cohort

Abbreviations: CRC, colorectal cancer; NA, not applicable; NSCLC, non-small cell lung cancer; PD, progressive disease; PR, partial response; SD, stable disease